Please assess the completion status of the following clinical trial:

Trial Title: A Low ChloridE hyperTonic Solution for Brain Edema

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Spontaneous SAH with an identified aneurysmal source as identified on neuroimaging obtained at admission to Emory University Hospital or with imaging at an outside hospital~* Age ≥ 18 years~Exclusion Criteria:~* SAH related to non-aneurysmal vascular anomaly~* SAH thought due to trauma~* SAH occurring in relation to another medical procedure (cardiac catheterization, LVAD placement, etc.)~* SAH with a negative workup for cause (angio-negative)~* Patients who arrive in a brain-death state or in a devastating clinical status that will be presumed to lead to brain death or early withdrawal of treatment~* Patient who suffer from end-stage renal disease at baseline and who are routinely treated with dialysis~* Known pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sodium chloride /sodium acetate (16.4%) (Type: EXPERIMENTAL): 50cc doses of sodium-chloride/sodium-acetate (16.4%) along with 30cc bag of dummy solution (PlasmaLyte).
- Sodium chloride (23.4%) (Type: ACTIVE_COMPARATOR): 30cc per dose of sodium chloride (23.4%) along with 50cc dummy solution bag (PlasmaLyte)

Based on this trial design, predict the completion outcome and termination type (if applicable).